Zantac litigation: One suit down, many more to go, GSK says
GSK’s first scheduled Zantac-cancer trial has been dismissed by the plaintiff, the British pharma company said, while noting that it did not settle the claim …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
